Results 1 to 10 of about 75,374 (162)
Vaccines, 2016 Viral hepatitis is a serious health problem all over the world. However, the reduction of the morbidity and mortality due to vaccinations against hepatitis A and hepatitis B has been a major component in the overall reduction in vaccine preventable ...
Kathleen Schwarz +2 more
exaly +5 more sources
The Journal of Infectious Diseases, 2021 Abstract Hepatitis B is caused by the hepatitis B virus (HBV), which infects the liver and may lead to chronic liver disease, including cirrhosis and hepatocellular carcinoma. HBV represents a worldwide public health problem, causing major morbidity and mortality.
Pattyn, Jade +3 more
openaire +4 more sources
Hepatitis C Vaccines, Antibodies, and T Cells [PDF]
Frontiers in Immunology, 2018 Naglaa H Shoukry, Shoukry Naglaa H
exaly +2 more sources
Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis
Revista da Sociedade Brasileira de Medicina Tropical, 2021 This article discusses viral hepatitis, a theme addressed by the Clinical Protocol and Therapeutic Guidelines to Comprehensive Care for People with Sexually Transmitted Infections and, more precisely, by the Clinical Protocols and Therapeutic Guidelines ...
Geraldo Duarte +4 more
doaj +1 more source
HBV Vaccines: Advances and Development
Vaccines, 2023 Hepatitis B virus (HBV) infection is a global public health problem that is closely related to liver cirrhosis and hepatocellular carcinoma (HCC). The prevalence of acute and chronic HBV infection, liver cirrhosis, and HCC has significantly decreased as ...
Faisal Mahmood +9 more
doaj +1 more source
Memorias do Instituto Oswaldo Cruz, 2012 Age-related seroprevalence studies that have been conducted in Brazil have indicated a transition from a high to a medium endemicity of hepatitis A virus (HAV) infection in the population.
Claudia Lamarca Vitral +15 more
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2020 Hepatitis A is an important public health issue worldwide. Hepatitis A vaccine (HepA) was first licensed in 1992. Both inactivated HepA (HepA-I) and live attenuated HepA (HepA-L) are highly immunogenic and well tolerated, and immune protection postvaccination can persist for at least 20 y.
openaire +3 more sources
Frontiers in Cellular and Infection Microbiology, 2021 ObjectivesTo compare the safety, immunogenicity, and immune persistence of hepatitis A (HA) vaccines between HBs-Ag-positive and -negative participants.Method9000 participants were enrolled in the phase IV study of live attenuated HA (HA-L) or ...
Xiaodan Wang +49 more
doaj +1 more source
Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review
Viruses, 2023 Vaccination has been confirmed to be the safest and, sometimes, the only tool of defense against threats from infectious diseases. The successful history of vaccination is evident in the control of serious viral infections, such as smallpox and polio ...
Ashraf Elbahrawy +7 more
doaj +1 more source
METHODS FOR ASSESSMENT OF THE SPECIFIC ACTIVITY OF DRUGS FOR PREVENTION OF HEPATITIS B
Вопросы вирусологии, 2017 The immunologic activity (specific activity) is one of the main indicators of quality of vaccines for prophylaxis of hepatitis B, along with their safety.
E. L. Postnova +3 more
doaj +1 more source